Dmitry Ter‐Ovanesyan
- Aging top 1%
- Cancer Research top 2%
- MicroRNA in disease regulation 7
- Molecular Biology top 2%
- Extracellular vesicles in disease 9
- CRISPR and Genetic Engineering 4
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 3
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Genetics top 10%
-
- Cell Adhesion Molecules Research 3
- Co-authors
- George M. ChurchMarcelle TuttleJames J. CollinsAlejandro ChavezBenjamin W. PruittAviv RegevEmma J. K. KowalBenjamin E. Housden
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Dmitry Ter‐Ovanesyan
18 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Aging 184
- Business and International Management 122
- Cancer Research 807
- Molecular Biology 3.2k
- Genetics 301
Countries citing papers authored by Dmitry Ter‐Ovanesyan
This map shows the geographic impact of Dmitry Ter‐Ovanesyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Ter‐Ovanesyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Ter‐Ovanesyan more than expected).
Fields of papers citing papers by Dmitry Ter‐Ovanesyan
This network shows the impact of papers produced by Dmitry Ter‐Ovanesyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Ter‐Ovanesyan. The network helps show where Dmitry Ter‐Ovanesyan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dmitry Ter‐Ovanesyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 39 | |
| 5 | 2021 | 160 | |
| 6 | 2021 | 32 | |
| 7 | 2017 | 20 | |
| 8 | 2017 | 132 | |
| 9 | Comparison of Cas9 activators in multiple speciesbreakdown → | 2016 | 381 |
| 10 | 2016 | 11 | |
| 11 | Cas9 gRNA engineering for genome editing, activation and repression | 2015 | 1 |
| 12 | 2015 | 249 | |
| 13 | 2015 | 1 | |
| 14 | Highly efficient Cas9-mediated transcriptional programmingbreakdown → | 2015 | 1183 |
| 15 | Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ Sitesbreakdown → | 2014 | 978 |
| 16 | 2013 | 121 | |
| 17 | 2012 | 34 | |
| 18 | 2009 | 25 |
About Dmitry Ter‐Ovanesyan
Dmitry Ter‐Ovanesyan is a scholar working on Immunology and Allergy, Cancer Research and Molecular Biology, having authored 18 papers that have together received 3.4k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (7 papers), CRISPR and Genetic Engineering (4 papers), RNA Interference and Gene Delivery (4 papers), Cell Adhesion Molecules Research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA modifications and cancer (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Aging (184 citations), Business and International Management (122 citations) and Cancer Research (807 citations). Dmitry Ter‐Ovanesyan has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include George M. Church, Marcelle Tuttle, James J. Collins, Alejandro Chavez, Benjamin W. Pruitt, Aviv Regev, Emma J. K. Kowal, Benjamin E. Housden, Norbert Perrimon and Samira Kiani. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.